No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr17:19481200-19485600 |
Weak transcription |
HepG2 |
liver
|
2 |
chr17:19482600-19484000 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
3 |
chr17:19482600-19484000 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
4 |
chr17:19482600-19484000 |
Bivalent Enhancer |
Placenta |
Placenta
|
5 |
chr17:19482800-19484000 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
6 |
chr17:19482800-19484000 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
7 |
chr17:19482800-19484000 |
Active TSS |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
8 |
chr17:19482800-19484000 |
Active TSS |
Brain Germinal Matrix |
brain
|
9 |
chr17:19483000-19484000 |
Bivalent/Poised TSS |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
10 |
chr17:19483000-19484000 |
Active TSS |
Breast Myoepithelial Primary Cells |
Breast
|
11 |
chr17:19483000-19484200 |
Bivalent/Poised TSS |
Stomach Smooth Muscle |
stomach
|
12 |
chr17:19483200-19484000 |
Bivalent/Poised TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
13 |
chr17:19483200-19484000 |
Bivalent/Poised TSS |
Skeletal Muscle Male |
skeletal muscle
|
14 |
chr17:19483400-19484000 |
Bivalent/Poised TSS |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
15 |
chr17:19483400-19484000 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
16 |
chr17:19483400-19484000 |
Active TSS |
Brain Angular Gyrus |
brain
|
17 |
chr17:19483400-19484000 |
Bivalent/Poised TSS |
Brain Hippocampus Middle |
brain
|
18 |
chr17:19483600-19484000 |
Flanking Active TSS |
Adipose Nuclei |
Adipose
|
19 |
chr17:19483600-19484000 |
Flanking Bivalent TSS/Enh |
Fetal Adrenal Gland |
Adrenal Gland
|
20 |
chr17:19483600-19484000 |
Flanking Bivalent TSS/Enh |
Fetal Muscle Trunk |
muscle
|
21 |
chr17:19483600-19484000 |
Flanking Bivalent TSS/Enh |
Fetal Muscle Leg |
muscle
|
22 |
chr17:19483600-19484000 |
Bivalent Enhancer |
Lung |
lung
|
23 |
chr17:19483600-19484000 |
Flanking Active TSS |
Ovary |
ovary
|
24 |
chr17:19483600-19484200 |
Bivalent/Poised TSS |
Rectal Smooth Muscle |
rectum
|
25 |
chr17:19483800-19484000 |
Bivalent/Poised TSS |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
26 |
chr17:19483800-19484000 |
Bivalent Enhancer |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
27 |
chr17:19483800-19484000 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
28 |
chr17:19483800-19484000 |
Bivalent Enhancer |
Primary hematopoietic stem cells |
blood
|
29 |
chr17:19483800-19484000 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
30 |
chr17:19483800-19484000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
31 |
chr17:19483800-19484000 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
32 |
chr17:19483800-19484000 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
33 |
chr17:19483800-19484000 |
Bivalent Enhancer |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
34 |
chr17:19483800-19484000 |
Enhancers |
Colon Smooth Muscle |
Colon
|
35 |
chr17:19483800-19484000 |
Bivalent Enhancer |
Duodenum Mucosa |
Duodenum
|
36 |
chr17:19483800-19484000 |
Enhancers |
Fetal Brain Male |
brain
|
37 |
chr17:19483800-19484000 |
Bivalent Enhancer |
Fetal Intestine Large |
intestine
|
38 |
chr17:19483800-19484000 |
Bivalent Enhancer |
Fetal Lung |
lung
|
39 |
chr17:19483800-19484000 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
40 |
chr17:19483800-19484000 |
Enhancers |
Spleen |
Spleen
|